miRNA在乳腺癌中的研究进展
CSTR:
作者:
作者单位:

武汉理工大学化学化工与生命科学学院/神经退行性疾病纳米医药湖北省重点实验室,武汉 430070

作者简介:

雷志鑫,E-mail:leizhixin@whut.edu.cn

通讯作者:

孙涛垒,E-mail:suntl@whut.edu.cn

中图分类号:

R - 05;R282.71;R737.9

基金项目:

国家自然科学基金项目(32202857)


Research progress of miRNA in breast cancer
Author:
Affiliation:

School of Chemistry,Chemical Engineering and Life Science/Hubei Provincial Key Laboratory of Nanomedicine for Neurodegenerative Diseases,Wuhan University of Technology,Wuhan 430070,China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    乳腺癌是全球3种最常见的癌症之一,对人类健康构成严重威胁。MicroRNA(miRNA)作为一种基因调控的小分子,可以介导细胞靶基因调控乳腺癌发生和发展进程。本文根据miRNA的来源进行分类并综述了当前已知内源性与外源性miRNA(植物元)的功能特性,并探讨这些miRNA在乳腺癌调控中的作用机制。同时,运用生物信息学预测乳腺癌相关的外源性miRNA潜在靶点,旨在为miRNA在乳腺癌治疗中的应用提供参考。

    Abstract:

    Breast cancer is one of the three most common cancers with the highest mortality rate in the world and poses a serious threat to human health.MicroRNA (miRNA),as a small molecule of gene regulation,can mediate cellular target genes to regulate the occurrence and development of breast cancer.In this paper,we classified miRNA according to their sources,reviewed the currently known functional properties of endogenous and exogenous miRNA (botanmin),and explored their regulatory mechanisms in breast cancer.At the same time,the potential targets of exogenous miRNA associated with breast cancer were predicted by bioinformatics,which provided a reference for their application in breast cancer therapy.

    参考文献
    相似文献
    引证文献
引用本文

雷志鑫,杨海旖,谢浩,环世娇,孙涛垒. miRNA在乳腺癌中的研究进展[J].华中农业大学学报,2024,43(5):149-156

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-09-28
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-10-08
  • 出版日期:
文章二维码